Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers*

The existence of receptor dimers has been proposed for several G protein-coupled receptors. However, the question of whether G protein-coupled receptor dimers are necessary for activating or modulating normal receptor function is unclear. We address this question with somatostatin receptors (SSTRs) of which there are five distinct subtypes. By using transfected mutant and wild type receptors, as well as endogenous receptors, we provide pharmacological, biochemical, and physical evidence, based on fluorescence resonance energy transfer analysis, that activation by ligand induces SSTR dimerization, both homo- and heterodimerization with other members of the SSTR family, and that dimerization alters the functional properties of the receptor such as ligand binding affinity and agonist-induced receptor internalization and up-regulation. Double label confocal fluorescence microscopy showed that when SSTR1 and SSTR5 subtypes were coexpressed in Chinese hamster ovary-K1 cells and treated with agonist they underwent internalization and were colocalized in cytoplasmic vesicles. SSTR5 formed heterodimers with SSTR1 but not with SSTR4 suggesting that heterodimerization is a specific process that is restricted to some but not all receptor subtype combinations. Direct protein interaction between different members of the SSTR subfamily defines a new level of molecular cross-talk between subtypes of the SSTR and possibly related receptor families.

[1]  H. Lother,et al.  Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization* , 1999, The Journal of Biological Chemistry.

[2]  P. Seeman,et al.  A Transmembrane Domain-derived Peptide Inhibits D1 Dopamine Receptor Function without Affecting Receptor Oligomerization* , 1998, The Journal of Biological Chemistry.

[3]  Brian Herman,et al.  Fluorescence imaging spectroscopy and microscopy , 1996 .

[4]  S. Khare,et al.  Agonist-dependent Up-regulation of Human Somatostatin Receptor Type 1 Requires Molecular Signals in the Cytoplasmic C-tail* , 1999, The Journal of Biological Chemistry.

[5]  P. Hayry,et al.  Differential regulation of somatostatin receptor types 1–5 in rat aorta after angioplasty , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[7]  C. Romano,et al.  Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.

[8]  Elli Kohen,et al.  Cell Structure and Function by Microspectrofluorometry , 1989 .

[9]  K. Clauser,et al.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. , 1991, Science.

[10]  G. Liapakis,et al.  Development of a selective agonist at the somatostatin receptor subtype sstr1. , 1996, The Journal of pharmacology and experimental therapeutics.

[11]  B. Kobilka,et al.  Co-expression of Defective Luteinizing Hormone Receptor Fragments Partially Reconstitutes Ligand-induced Signal Generation* , 1997, The Journal of Biological Chemistry.

[12]  Kenneth A. Jones,et al.  GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 , 1998, Nature.

[13]  E. Whitehorn,et al.  A generic method for the production of cell lines expressing high levels of 7-transmembrane receptors. , 1997, Analytical biochemistry.

[14]  F. Marshall,et al.  GABAB receptors - the first 7TM heterodimers. , 1999, Trends in pharmacological sciences.

[15]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[16]  C. B. Srikant,et al.  Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. , 1994, The Journal of biological chemistry.

[17]  C. Reynolds,et al.  Simulations on dimeric peptides: evidence for domain swapping in G-protein-coupled receptors? , 1997, Biochemical Society transactions.

[18]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[19]  C. B. Srikant,et al.  Somatostatin Receptor: Evidence for Functional and Structural Heterogeneity , 1987 .

[20]  J. Wess,et al.  Use of a Disulfide Cross-linking Strategy to Study Muscarinic Receptor Structure and Mechanisms of Activation* , 1999, The Journal of Biological Chemistry.

[21]  G. Köhr,et al.  Role of heteromer formation in GABAB receptor function. , 1999, Science.

[22]  Alan Wise,et al.  Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.

[23]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[24]  K. Sakimura,et al.  Molecular diversity of the NMDA receptor channel , 1992, Nature.

[25]  M. Thangaraju,et al.  Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. , 1999, Diabetes.

[26]  T M Jovin,et al.  Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation , 1995, The Journal of cell biology.

[27]  R. Shigemoto,et al.  GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.

[28]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Y. Patel Somatostatin and Its Receptor Family , 1999, Frontiers in Neuroendocrinology.

[30]  H. O. Onaran,et al.  Ligand efficacy and affinity in an interacting 7TM receptor model , 1999 .

[31]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[32]  T. Hirschfeld,et al.  Quantum efficiency independence of the time integrated emission from a fluorescent molecule. , 1976, Applied optics.

[33]  D. Goeddel,et al.  Interferon-gamma induces receptor dimerization in solution and on cells. , 1993, The Journal of biological chemistry.

[34]  Pierre Corvol,et al.  Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling , 1996, The Journal of Biological Chemistry.

[35]  S. Hjorth,et al.  Ligand binding pocket of the human somatostatin receptor 5: mutational analysis of the extracellular domains. , 1997, Molecular pharmacology.

[36]  U. Kumar,et al.  The Cytoplasmic Tail of the Human Somatostatin Receptor Type 5 Is Crucial for Interaction with Adenylyl Cyclase and in Mediating Desensitization and Internalization* , 1998, The Journal of Biological Chemistry.

[37]  E. Brown,et al.  Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells* , 1998, The Journal of Biological Chemistry.

[38]  Michel Bouvier,et al.  Structural and functional aspects of G protein-coupled receptor oligomerization. , 1998 .